Genetics is increasingly becoming a part of modern medical practice. How people think about genetics' use in medicine and their daily lives is therefore essential. Earlier studies indicated mixed attitudes about genetics. However, this might be changing. Using the preferred reporting items for systematic reviews and meta-analyses (PRISMA) as a guideline, we initially reviewed 442 articles that looked at awareness, attitudes, knowledge, and perception of risks among the general and targeted recruitment populations. After fitting our criteria (from the last 5 years, conducted in the USA, non-provider populations, quantitative results reported, and assessed participants 18 years and older), finally 51 eligible articles were thematically coded and presented in this paper. Awareness is reported as relatively high in the studies reviewed. Attitudes are mixed but with higher proportions reporting positive attitudes towards genetic testing and counseling. Self-reported knowledge is reasonably high, specifically with the effects of specific programs developed to raise knowledge levels of the general and targeted recruited populations. Perception of risk is somewhat aligned with actual risk. With the reasonable positive reports of genetic awareness and knowledge, there is similar positive attitude and perception of risk, supporting the need for continued dissemination of such knowledge. Given interest in incorporating community participation in genomic educational strategies, we provide this review as a baseline from which to launch community-specific educational supports and tools.
Introduction
Genetics is becoming a more significant component of modern medicine and has interfaced with many parts of the average person's life-from newborn screening to agriculture, family planning, and consumer products. For example, the National Cancer Institute has been a leader in the integration of genetics into medical practice (McCormick and Calzone 2016) . The National Human Genome Research Institute has been engaging communities for several years to design and improve educational strategies with the goal of bringing more diverse perspectives into the research and policy-making process (genome.gov). The Community Engagement in Genomics Working Group, a partnership between numerous community leaders and NHGRI staff, set the goal of understanding the knowledge, attitude, awareness, and perceived risk of genetics operating in their communities.
To accomplish this goal, we sought an understanding of what is currently known in the literature to inform their strategies for soliciting this information and interpreting it against the national landscape. Early research on how people viewed genetics contained both positive and negative perspectives (Singer et al. 2008 ). But it is unclear how this has changed, especially with the increased focus on genetic awareness of the last decade. As genomics and genetic testing become more embedded in common medical procedures, acceptance by the general public might be very relevant to implementation and use. The present study reviews the current literature on what people in the US report about genetics: their attitudes, knowledge, awareness, and perceptions. This review provides the background setting needed to assist the development of community-specific and population-level assessment and engagement tools to increase community participation in the broader genomics discussion.
Methods for the present review
We present the results of a systematic review of the existing quantitative measures of stakeholder engagement in published research and programs. We used the methods of Preferred Reporting Items for Systematic Reviews and Meta-Analyses to review the literature on measures of genetic understanding (Moher et al. 2009 ).
Phase 1: searching the literature
With assistance from a reference librarian and previously published research, we generated a master list of search terms to use in the PubMed database (Bowen et al. 2017) . The following Medical Subject Headings (MeSH) terms were selected: genetic testing, genetic counseling, attitude, knowledge, awareness, and perception. These terms were then entered into the chosen database using quotations to ensure that search terms were verbatim and genetic testing and genetic counseling were separated by OR, while attitude, knowledge, awareness, and perception were separated by AND to ensure inclusion if any of the search terms were present. A master list of articles (n = 442) resulted from these search results.
Search methods
We searched the peer-reviewed literature using an electronic bibliographic database: PubMed (Web-based). This database search for all years from 2012 to 2016 occurred between May 2017 and June 2017. Exclusion of articles occurred if they surveyed children (defined in this paper as those under the age of 18) or providers (including genetic counselors), were conducted outside of the USA, only reported qualitative data, and did not cite a tool to assess knowledge, awareness, attitudes, or perceived risk.
Phase 2: abstract review
We independently reviewed each title and abstract using predetermined inclusion and exclusion criteria and resolved disagreements through re-review and discussion until they reached consensus. Included articles appear in English, in a peerreviewed journal, report original research, had quantitative findings, and were conducted in the USA. The full texts of articles whose abstracts met our inclusion criteria were retrieved and then examined for further inclusion/exclusion criteria.
Phase 3: data abstraction
To ensure consistency in data abstraction, we created a standardized codebook for use by all authors, based on a prior measurement review (Bowen et al. 2017) . The codebook included definitions of the four content areas so that studies could efficiently be coded as having one or more of the constructs present in the study. Two authors reviewed the same studies using the codebook and identified and resolved disagreements in coding, resulting in a revised final codebook. For all studies included in the review, two authors independently coded and compared their results. Coding discrepancies within pairs found resolution through discussion among authors. We opted for this consensus method, because of the enormous variability in terminology and quality used to describe engagement characteristics and constructs across studies.
The variables extracted the following data from each article: study design, population/sample, intervention, tools used, and findings. Data entered into Excel files, and evidence tables were constructed, organized by article first author, and stratified by type of construct. Articles with more than one construct appear under every construct mentioned in the article, meaning that some articles will appear in the table more than once.
The flow of diagram or article review Figure 1 contains the data on article eligibility and coding patterns. The search identified 442 articles using our keywords. After duplicates removed, 437 articles remained. All 437 were screened by reading the abstracts and determining if it fits our previously established eligibility requirements. Three hundred sixty-one articles did not meet our eligibility requirements, leaving 76 articles left. These articles were read in full and coded for data. Further exclusion of 25 articles occurred due to not meeting our criteria, not reporting quantitative data, not reporting any data (study design papers), or being an international article. Fifty-one articles met all criteria and were included in the analysis. Tables 1 and 2 summarize the articles reviewed. We divided the abstracted measures into (1) those focused on a populationbased sample and (2) those focused on a targeted or limited sample (such as a high-risk genetic group or a specific ethnic group). For each grouping, we further categorized the content into four areas: attitudes, knowledge, awareness, and perceived risk. This was done by coding the outcomes measured by one or more of the categories provided. We also labeled the articles as having an intervention, depending on study design. Some articles are listed under more than on content area and are marked as such on the tables. While some of these were hard to differentiate, they provide a method of focus for the review. Table 1 presents the studies that contained an attempt at a population-based sample.
Results

General populations
Awareness
Two articles addressed the general public's awareness of genetic testing or genetic screening. Mai et al. compared awareness from 2000, 2005, and 2010 national health interview surveys and found that while awareness significantly decreased from 44.4 to 41.5% from 2000 to 2005 (p < .001), it significantly increased to 47% in 2010 (p < .001) (2014). This finding is similar to results in a smaller study by Riesgraf et al. which surveyed rural residents (n = 203) from the Midwest and found 47.4% of participants reported they had heard of genetic counseling (2015) . Two articles looked explicitly at awareness of direct-to-consumer (DTC) genetic tests. Agurs-Collins et al. found that only 35.1% had ever heard or read about DTC genetic tests (2015) . Kolor et al. found that awareness was even lower, with percentages ranging from 29.1% (CI 26.4-31.9%) in Oregon to 15.8% in Michigan (CI 14.6-17.1%) with a national average being 22.1% (CI 21.0-23.2%) (2012).
One article assessed awareness among the general public of genetic nondiscrimination laws. Parkman et al. found that less than 20% of the adult population were aware of genetic nondiscrimination laws, despite 80% reporting that such laws would be very important (2015).
Attitudes
One article contained attitudes of preimplantation genetic diagnosis (PGD). Winkleman et al. found that the majority of respondents supported PGD to screen for genetic diseases, specifically 72.9% supported screening for Bdiseases that are fatal in the first few years of life^, 66.7% supported screening for Bdiseases that cause lifelong disability^, and 48% supported screening for Bdiseases that may not occur until later in life^ (2015) .
Six articles addressed attitudes towards prenatal genetic testing and screening, with half of the articles explicitly looking at attitudes towards noninvasive prenatal screening/ testing (NIPS/NIPT). A study in which participants looked at mock news articles on either NIPS, amniocentesis, or no article, Higuchi et al. found that those assigned to the mock NIPS article predicted stronger agreement that pregnant women should choose prenatal testing (OLS .297, p < .001) (2016). Steinbach et al. found similar results, with a majority (71.9%) of respondents supporting the use of NIPS, either alone or in combination with other prenatal genetic tests (2016). Farrell et al. found that women, both of low and high-risk pregnancies, expressed support for incorporating NIPT into their prenatal care (2014). Two articles addressed attitudes towards prenatal testing for trisomy 13 and 18 and trisomy 21. In a study where participants were randomized to a survey about cell-free fetal (cff) DNA testing for either trisomy 13 and 18 or trisomy 21, Allyse et al. found that there was substantive interest in the use of cffDNA testing rather than traditional screening mechanisms, with little difference between the groups (trisomy 13/18 37.7%, trisomy 21 38.9%) (2014). In Two articles looked at attitudes towards genetic testing for cancer among the general public. In a survey of attitudes towards pan-digestive cancer screening using a multi-organ stool DNA test (MUST), Yang et al. found that 96% of participants would use MUST (2014) . In a follow-up to community survey of knowledge and beliefs about cancer and genetics, Sweeney et al. found that the majority (83%) of respondents said they would be willing to take a genetic blood test, higher than the 2001 survey (78%) (2016) .
A study on actionability and disease severity in the context of genetic testing found that the majority of participants (n = 900) found both actionability (87%) and disease severity (85%) useful when deciding what genomic results they might want to learn . A study on general attitudes towards genetic testing found that attitudes in their sample were relatively split, with just about half (47.6%) of participants eventually undergoing genetic testing (Shiloh et al. 2013) . This is consistent with Riesgraf et al. who found among participants in a study on attitudes about genetic counseling, specifically that willingness to undergo genetic counseling was evenly split, with 54.7% indicating they would use genetic counseling and 45.3% indicating there were no circumstances in which they would use genetic counseling (2015). Finally, Taber et al. found that perceptions of genome sequencing results were favorable (2015).
Knowledge
Four articles looked at the general public's knowledge of genetic testing and counseling. Ostergren et al. found that among 1030 direct-to-consumer genetics test participants, there was high comprehension, with an average knowledge score of 79.1% correct (2015). Haga et al. found similar findings, with an average participant score of factual knowledge of genetics of 84% (2013). Carere found that among DTC customers, genetic knowledge was relatively high, with an average baseline score of 8.15 (out of 9) (SD.95) (2016). In a study comparing prenatal genetic knowledge among parous vs. nulliparous women, Mandelberger et al. found that parous women scored significantly higher than nulliparous women on the fundamental genetics quiz (70.9 vs. 61.9%, p < .03) (2015) .
Three articles examined how knowledge of genetic testing and counseling would increase after an intervention. Schwartz et al. conducted a study comparing usual care for in-person genetic counseling to telephone genetic counseling and found Article is used in more than one category that post-counseling knowledge score, although not reaching statistical significance, was .03 points higher among telephone counseling participants versus usual care counseling participants (2014). In a randomized trial comparing participants assigned to either an interactive prenatal genetic testing information aid or standard care counseling, Yee et al. found that participants randomized to the interactive tool correctly answered a more significant amount of questions than those randomized to receive usual care counseling (2014). Wolfe et al. created an online tutoring program for patients considering BRCA testing and compared participants assigned to their BRCA Gist program with participants assigned to the National Cancer Institute website and a control group (2015). They found that the BRCA Gist participants scored significantly higher than National Cancer Institute website participants (p < .001), and both scored significantly higher than control group participants (p < .001) (Wolfe et al. 2015) .
Perception of risk
Two articles looked at perceived risk after DTC tests. Carere et al. found that elevated risk results associated significantly with a positive change of perceived risk (p < .02), meaning that perceived risk increased when participants received elevated risk results (2015). Boeldt et al. found that among DTC customers, the most commonly cited perceived risks were for heart attack (19.1%) and Alzheimer's disease (18.6%) (2015). Table 2 presents the articles that recruited a targeted or selected sample.
Targeted recruitment
Awareness
Three articles looked at awareness of genetic counseling or testing. In a study of patients undergoing testing for Lynch syndrome, Patel et al. found that 63% (n = 104) had heard of genetic testing, with a higher number of patients from highrisk clinics reporting they had heard of genetic testing than those recruited from the general population clinics (71.3 vs. 52.1%, p < .015) (2016). In a study of high-risk Latinas undergoing BRCA genetic counseling, Sussner et al. found that more than half of participants had heard or read Balmost nothing^or Brelatively little^about BRCA genetic counseling (2013). Armstrong et al. found that awareness of genetic counseling related to physician recommendation, with only 36.8% of patients reporting receiving genetic counseling before testing (2015) .
Attitudes
One of the articles focused on attitudes towards prenatal and genetic testing in children. In a study of parents of children affected with Treacher Collins syndrome (TCS), Wu et al. found that 65% of participants reported that the risk of having a child with TCS was of a more significant concern than the risk of miscarriage from prenatal genetic testing (2012). Also, the likelihood of undergoing genetic testing or having their child undergo genetic testing was dependent on how accurate the hypothetical test was, with 87% reporting they would undergo prenatal genetic testing if accuracy were 100% vs. just 6.5% stating they would undergo prenatal genetic testing if accuracy were only 20% (Wu et al. 2012) . Four of the articles tried to identify parental attitudes towards genetic testing in children. In a study of parents with multiple affected offspring with epilepsy, Caminiti et al. found that 85.7% of these parents responded with Bdefinitely or probably yes^for genetic testing with clinical utility and 100% penetrance (2016). However, 74% of parents of no affected offspring responded positively to genetic testing for their offspring (Caminiti et al. 2016 ). This positive attitude towards genetic testing in children is consistent in other studies, such as Fitzgerald-Butt et al. who found that among parents of children with congenital heart defects, 57.9-89.4% (SD 19.1%) of participants were Bsomewhat likely or very likely^to undergo genetic testing for their children (2014). Narcisa et al. also found that among parents of at least one child diagnosed with Autism Spectrum Disorder (ASD), that 80% of participants who had a younger, as of yet undiagnosed child, would Bwant their child tested even if it could not confirm or rule out a diagnosis^(2012). It is not just genetic tests that parents are generally in favor of; it is genetic counseling as well. Waxler et al. found that parents of children diagnosed with Williams Syndrome were more likely to have a positive or mixed diagnostic experience if they saw a genetic counselor (n = 386, 81.60%) (2013).
Positive attitudes towards genetic testing are present when considering genetic testing for cancer in adults. O'Neill et al. found that among young college-aged smokers, participants held moderately strong intentions for GSTM1 enzyme testing (5.21 on a 7-point scale) (2013). Yusuf et al. found similar results among breast cancer patients, who were Bgenerally willing to undergo molecular testing biopsies, and blood draws to guide therapy (75%) and research (46%)^(2015). Similar attitudes presented among high-risk Latinas who had mostly positive attitudes about BRCA genetic counseling (Sussner et al. 2013) .
Positive attitudes occurred among participants of studies of genetic testing for non-cancer diseases. Among participants with Alcohol Use Disorder, Scott et al. and Strobel et al. found that 85% (n = 259) and 89%, respectively, expressed willingness to test and provide genetic samples for clinical use (Scott et al. 2014; Strobel et al. 2013) . In a study looking at genetic testing for Alzheimer's disease, Caselli et al. found that 70.4% (2775/3939) were willing to undergo presymptomatic testing even in the absence of any effective intervention (2014) . In a study of genetic testing for patients with irritable bowel disorder (IBD), Hooker et al. found that patients perceived the genetic test as more useful for understanding disease etiology and family risks than the standard test (p < .001) (2014). Freedman et al. found that family members of a loved one with nephropathy had intentions to undergo genetic testing (2013). Only one study identified a group that had a more negative attitude towards genetic testing. In a study of veterans and their families on genetic testing for PTSD, Dedert et al. found that compared with non-PTSD participants, those with PTSD had significantly less favorable attitudes towards genetic testing (p < .05) (2012).
Regarding attitudes related to genetic testing in general, Allain et al. found that only 54.3% of participants had heard of the Genetic Information Nondiscrimination Act (GINA) (2012). Also, Matro et al. found that there was a high willingness-to-pay for genetic testing, with 79% (n = 303) willing to pay out-of-pocket, and just 21% (n = 82) were only willing to be tested if entirely covered by insurance (2014).
Knowledge
Overall, genetic knowledge was relatively high among targeted samples. Fitzgerald-Butt et al. found in a study of parents with children who had a congenital heart defect that the mean genetic knowledge summary score was 73.8% correct, with questions on the interaction of the environment and genetics being answered correctly the most, and underlying genetic knowledge being answered correctly the least (2014). Similarly, in a study of parents with children with Batten Disease, Adams et al. found that the mean total score on knowledge questions was 84% correct (SD 11%) (2014). In a study among high-risk Latinas seeking BRCA genetic testing, Sussner et al. found that mean knowledge of genetic counseling was Bfairly high^(2013). Patel et al. found that participants from high-risk clinics scored significantly higher on colorectal cancer screening knowledge than those recruited from general population clinics (35.1 vs.12.7%, p < .001) (2016). There was one study in which the majority of participants did not have high knowledge. In a study of patients at a private IVF clinic, Gebhart et al. found that 69% of participants reported no previous knowledge of preimplantation genetic screening before the IVF treatment cycle (2015) .
One study assessed the impact of an intervention on genetic knowledge. Gallo et al. conducted a study of participants with sickle cell disease or trait and assigned them to an e-book, CHOICES in-person intervention, or no intervention (2016). At 24 months, both e-book and CHOICES participants had higher knowledge scores compared to controls, with participants in the CHOICES intervention having a significantly higher knowledge improvement rate over time than the e-book group (p < .004) (Gallo et al. 2016) .
In a study of undergraduate students in a genetics course, Weber et al. assessed whether genetics quiz scores would increase if students were given the opportunity to look at their genetic information and found that student anticipation of obtaining their genomics data did not result in improved personal genomics quiz scores (2015).
Perception of risk
Three studies looked at the perception of genetic risk among targeted study participants. Andersen et al. found that highrisk women with a family history of breast or ovarian cancer were significantly more likely than others to perceive their risk of breast cancer to be higher than others their age (65.7 vs. 42.1%, p < .05) (2016). In a study on breast cancer risk perception among relatives of family members who tested negative for BRCA mutations, two-thirds of respondents stated their perceived risk of carrying the BRCA1/2 mutation was Bsomewhat, very, or extremely^likely (Sussner et al. 2013 ). Tong et al. looked at the intentions for risk-reducing surgery among high-risk women referred for BRCA counseling and found that perceived breast cancer risk was associated with 14-16% (p < .001) increased odds of considering a riskreducing mastectomy and that women with a higher perceived mutation risk had a 74% (p < .007) increased odds of considering risk-reducing oophorectomy (2015) . One article assessed perceptions of risk after genome sequencing among sisters and daughters who had tested negative for a BRCA 1/2 mutation and found that those who shared with their family what their genetic counselor told them had a more accurate perception of risk (Himes et al. 2016 ).
Discussion
Community leaders have expressed a desire to measure awareness and understanding of genomics (Kaplan et al. 2017) . To enable an internal assessment, we identified the need to have tools that can measure the general awareness, attitudes, knowledge, and perceived risk of genomics in the general population. The findings surfaced here provide interesting starting points to inform the use of assessment tools to further inform educational strategies.
This review systematically scanned the literature to identify what people think about genetics. We found that in general people report high levels of knowledge and positive attitudes about genetics. Knowledge scores and attitudinal ratings among both general populations and targeted samples were high. Intervention data, while limited, indicate slight improvements in knowledge, possibly because of the high baseline values. A recent summary and review presented at a national meeting (Kaphingst 2018) found that knowledge can be measured differently and is often poorly defined, indicating that this should be an area of future research. If general knowledge about genetics is only weakly useful to people making decisions about testing and interpretation, then other variables might be influencing behaviors regarding genetics and could be better conceptualized and measured.
As access to genetic tools expands, more public exposure to genomics and genomics education could occur during a variety of activities such as visiting the doctor, having a baby, watching the nightly news, and through social conversations. As genomics further intersects with law, public health, medicine, agriculture, research, politics, and consumer products, decision-making in the field of genomics will have considerable consequences to members of the public and specific patient and community groups. It is essential that people have the appropriate tools to actively participate in broader discussions and decision-making, especially in setting policy, research priorities, protections, and strategies for equitable inclusion. Citizen groups are actively seeking informational sources for foundational knowledge of genomics, its applications, and the ethical considerations to enable and empower them to further engage with genomic issues and decisionmaking (Follett and Strezov 2015) . In response, educators, clinicians, researchers, and the governmental representatives have convened to understand better how to meet overall and specific needs for genetic knowledge and understanding.
One of the interesting findings to come from this review is the alignment of attitudes and awareness reports of genetic testing, when the actual tests studied, situations, and populations are quite different. Generally, people report positive attitudes about genetics, despite differences in the uses of genetic technology and findings for diagnostic and clinical decisions, as well as general judgments about genetic utility. One explanation for this is that individual respondents are not considering the individual differences among all the different ways that genetic knowledge and testing can be used and the various ramifications that results can have. Clearer definitions of what is being measured and how the engaged sample defines the testing under scrutiny might clarify this. Also, more careful conceptualization of what is meant by knowledge and what aspects of knowledge are relevant to the problem under study could clarify this (Kaphingst 2018) . General knowledge about DNA might not be relevant in a situation where testing reveals a child at risk of a later-onset disease process.
Further complicating this picture is the use of hypothetical situations as cues for responses to surveys as opposed to actual cases in which genetics is relevant to medical decisions. In this review, we found that attitudes towards genetic testing in the hypothetical were quite high. We first saw this gap between the early research on the predicted uptake of Huntington's disease testing as potentially very high, and the actual uptake when offered, which was several percentage points lower. This discrepancy points to the need for better more careful research into what people think about genetics in specific situations (Forrest et al. 2012) .
In the studies we reviewed on public awareness, it seems that only about half or less of the general public reports awareness of genetics as useful or relevant. Though this is impressive, a substantial part of the population is still unaware of genetics. Of those who have some awareness, reports are positive towards testing, though this is not surprising given that a majority of those who encounter genomic education come through the clinic. There is high general support for the use of genetic testing preimplantation during assisted reproduction and high interest in personalized testing in general, for example among children of adults with incurable dementiarelated diseases. Genomics is also perceived to be a tool in supporting treatment of childhood conditions. Interestingly, a significant gap exists between someone's stated willingness to utilize genetic testing and pursuing I, as indicated by the relatively positive attitudes about genetics compared to the national uptake of testing in the general public, which is low (Wilkes et al. 2017 ). This could be due to concerns regarding how genetic information is used, especially in determining access to health and life insurance. Further, many people are not aware of the current federal protections in place, as found in the review.
Those who encounter genomics in the clinical setting (targeted recruitment) have a slightly higher knowledge of the subject than the general population. Targeted populations perceive genomic medicine as a tool providing critical information when faced with medical decisions. Attitudes in targeted population towards the use of genomic technology are positive for understanding disease etiology, risk brackets, and treatment plans. Of the targeted populations surveyed, there were also negative attitudes when associating genetics with PTSD. Given the historical misuse of genetic data and the intersection of genomics with social stigma and ill-informed perception, it is vital the attitudes and perceived risk of people surveyed are from all stakeholders involved in the outcomes of decision-making.
The research on the knowledge, awareness, attitudes, and perceived risk beyond patients engaged in health care is considerably sparser. This research essentially has excluded a diverse sample of participants, participants who do not have access to health care or access care through fragmented systems that do not have easy methods of collecting survey data. We need to understand how broader, more diverse population samples view genetics and how people receive care in public clinics and through more patchwork systems and referrals understand and use genetic information. Targeting assessments to such settings is one solution for filling this gap. Another idea is to create more forums that provide knowledge on genomics and opportunities to discuss the application of genomics tools to modern life. Because genetic counseling has been an important source of education of familial genetics, including a discussion of broader ethical, legal, and social issues into clinic settings is an important mechanism of disseminating information through the family and their more expansive network. Given the limited access and availability of genetic counseling and the barriers to receiving genomicsinformed care, investing in community-driven genomics educational strategies is ideal. In developing community-specific educational strategies, special attention should focus on groups that are absent from historical and current conversations on genetics, health, research, or policy Brandt et al. 2008; Sadler et al. 2010; Doherty et al. 2004; Khoury et al. 2003) . Successful partnerships and educational strategies require recognition and validation of previous social misuse of genetic data.
